Targovax AS 

0
29
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-3.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TA5.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Show more...
CEO
Erik Digman Wiklund
Employees
9
Country
Other
ISIN
NO0010689326
WKN
000A3EUN9

Listings

0 Comments

Share your thoughts

FAQ

What is Targovax AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Targovax AS stocks are traded under the ticker TA5.MU.
What is Targovax AS revenue for the last year?
Targovax AS revenue for the last year amounts to 0 EUR.
What is Targovax AS net income for the last year?
TA5.MU net income for the last year is -3.88M EUR.
How many employees does Targovax AS have?
As of September 04, 2026, the company has 9 employees.
In which sector is Targovax AS located?
Targovax AS operates in the Health & Wellness sector.
When did Targovax AS complete a stock split?
The last stock split for Targovax AS was on October 04, 2023 with a ratio of 1:30.
Where is Targovax AS headquartered?
Targovax AS is headquartered in Oslo, Other.